BD investigating reports of false positives from COVID-19 tests
By
Danielle Brown
Sep 16, 2020
New Jersey-based medical technology company Becton Dickinson, or BD, is conducting an investigation following reports that its COVID-19 point-of-care testing equipment is producing false positive results...
HHS extends coverage for COVID-19 screening at nursing homes
By
Danielle Brown
Sep 01, 2020
Nursing homes in states that prohibit the use of point-of-care COVID-19 tests to screen for the disease can now do so after the Department of Health and Human Services extended coverage to include congregate...
Medicare would cover breakthrough technology quicker under CMS proposal
By
Danielle Brown
Sep 01, 2020
Nursing home residents would have more access to new and breakthrough technology as treatment options under a new Medicare coverage pathway proposed by the federal health officials.
FDA approves $5 rapid-results COVID antigen test
By
Alicia Lasek
Aug 28, 2020
The test involves a credit-card-sized device that functions like some pregnancy tests. The developer expects to begin shipping large quantities in September.
Masks arrive from ‘dubious’ sources, bearing false FDA certificates: report
By
Alicia Lasek
Jul 21, 2020
In a rush to meet demand for face masks and respirators, some manufacturers have turned out poor quality products while claiming federal approval, according to a new report.
Biogen seeks FDA approval for Alzheimer’s drug; aims to be first to slow disease
By
Alicia Lasek
Jul 09, 2020
Treatment with aducanumab reduced declines in memory, language, and activities of daily living performance, the drugmaker says.
FDA approves fast-results antigen test for COVID-19
By
Alicia Lasek
May 11, 2020
The first federally approved test of its kind, the point-of-care diagnostic is administered using a nasal swab.
Clinical Daily Briefs for Thursday, March 26
By
Alicia Lasek
Mar 25, 2020
Argentum, AHCA / NCAL launch campaigns to share positive messages during pandemic … Clinic study shows where surface-cleaning efforts can fall short … CVS moves to prevent hoarding of malaria drug...
Ambien alternative? FDA approves insomnia drug that improves sleep in seniors
By
Alicia Lasek
Jan 01, 2020
New insomnia medication lemborexant compared favorably to an extended release form of Ambien in a late-stage clinical trial.
Promising antidepressant fails in late-stage trial
By
Alicia Lasek
Dec 05, 2019
Fast-tracked antidepressant Sage-217 failed to outperform a placebo in a stage 3 trial, according to its developer.